Literature DB >> 3919977

Complement activation by circulating serum factors in human glomerulonephritis.

S Meri.   

Abstract

Factors with the ability to induce a minimum of 20% C3 conversion in normal human serum (NHS) were demonstrated in the sera of nine glomerulonephritis (GN) patients. The nature of these factors was heterogeneous allowing their division into at least three different groups. First, in three cases (membranoproliferative or acute GN) they exhibited the characteristics of C3 nephritic factor, an IgG autoantibody stabilizing the alternative pathway (AP) C3 convertase, C3bBb. Secondly, the serum of one patient (SLE like syndrome, mixed cryoglobulinaemia) with an activator of both pathways and profound hypocomplementaemia showed a temperature-dependent precipitation against autologous and homologous polyclonal IgG. Immunochemical analysis suggested this activity to be due to a monoclonal IgM kappa rheumatoid factor. By gel filtration the C3 converting activity was found in the high molecular weight fractions containing the cryoprecipitable IgM-IgG complexes. Finally, in five cases the exact nature of C-activating factors remained unknown. In four of these the factors were heat labile (30 min at 54 degrees C) C activators in association with post-streptococcal glomerulonephritis. The results suggest that the various C activating factors, possibly distinct from 'classical' immune complexes, are indicators of different types of pathogenetic mechanisms in certain forms of GN.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3919977      PMCID: PMC1577145     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Role of C3b in the breakdown of C3 in hypocomplementaemic mesangiocapillary glomerulonephritis.

Authors:  D G Williams; P J Lachmann; J A Charlesworth; D K Peters
Journal:  Lancet       Date:  1973-03-03       Impact factor: 79.321

2.  C3 breakdown by serum from patients with acute post-streptococcal nephritis.

Authors:  D G Williams; O Kourilsky; L Morel-Maroger; D K Peters
Journal:  Lancet       Date:  1972-08-19       Impact factor: 79.321

3.  Classical complement pathway activation in membranoproliferative glomerulonephritis.

Authors:  Y M Ooi; E H Vallota; C D West
Journal:  Kidney Int       Date:  1976-01       Impact factor: 10.612

4.  Nephritic factor: its structure and function and its relationship to initiating factor of the alternative pathway.

Authors:  R D Schreiber; O Götze; H J Müller-Eberhard
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

5.  Studies of serum complement in the hypocomplementaemic nephritides.

Authors:  D G Williams; D K Peters; J Fallows; A Petrie; O Kourilsky; L Morel-Maroger; J S Cameron
Journal:  Clin Exp Immunol       Date:  1974-11       Impact factor: 4.330

6.  Human glomerulonephritis and the C3 nephritic factor (C3NeF).

Authors:  F C Berthoux; C B Carpenter; A M Freyria; J Traeger; J P Merrill
Journal:  Clin Nephrol       Date:  1976-03       Impact factor: 0.975

7.  Immunofixation. I. General principles and application to agarose gel electrophoresis.

Authors:  R F Ritchie; R Smith
Journal:  Clin Chem       Date:  1976-04       Impact factor: 8.327

8.  The complement abnormalities of lipodystrophy.

Authors:  J G Sissons; R J West; J Fallows; D G Williams; B J Boucher; N Amos; D K Peters
Journal:  N Engl J Med       Date:  1976-02-26       Impact factor: 91.245

9.  C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase.

Authors:  M R Daha; D T Fearon; K F Austen
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

10.  Serum factors activating the alternative complement pathway in autoimmune disease: description of two different factors from patients with systemic lupus erythematosus.

Authors:  C M Arroyave; M R Wilson; E M Tan
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

View more
  4 in total

1.  Causes of alternative pathway dysregulation in dense deposit disease.

Authors:  Yuzhou Zhang; Nicole C Meyer; Kai Wang; Carla Nishimura; Kathy Frees; Michael Jones; Louis M Katz; Sanjeev Sethi; Richard J H Smith
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-05       Impact factor: 8.237

2.  C3 Glomerulopathy and post-infectious glomerulonephritis define a disease spectrum.

Authors:  Badria Al-Ghaithi; Rahul Chanchlani; Magdalena Riedl; Paul Thorner; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2016-03-23       Impact factor: 3.714

3.  Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement.

Authors:  Sanjeev Sethi; Fernando C Fervenza; Yuzhou Zhang; Ladan Zand; Nicole C Meyer; Nicolò Borsa; Samih H Nasr; Richard J H Smith
Journal:  Kidney Int       Date:  2012-12-12       Impact factor: 10.612

4.  Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis.

Authors:  S Meri; V Koistinen; A Miettinen; T Törnroth; I J Seppälä
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.